DEVELOPMENT OF VESIVAX CO-ADJUVANT FORMULATION OF 2E151.
$599,925
| Recipient | MOLECULAR EXPRESS, INC UEI R1JMHFESEKD5 |
|---|---|
| Award ID | 75N93023C00033 |
| Award amount | $599,925 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | AN12 |
| Set-aside | Unrestricted |
| Start date | Sep 30, 2023 |
| End date | Sep 29, 2025 |
| Place of performance | COMPTON, CA |
| Record updated | Sep 11, 2023 |
View the official award record
More awards won by MOLECULAR EXPRESS, INC
VESIVAX TLR7 FORMULA
Department of Health and Human Services · $2,999,352 · Sep 1, 2024
THE CONTRACTOR SHALL TO EVALUATE THE DIFFERENT CO-DELIVERY METHODS OF A MODEL HIV ANTIGEN USING THE VESIVAX LIPOSOMAL PLATFORM.
Department of Health and Human Services · $2,294,565 · Jul 1, 2021
DESIGN AND ENGINEERING OF VESIVAX HIV IMMUNOGEN FORMULATIONS
Department of Health and Human Services · $1,999,866 · Jul 1, 2024
DEVELOPMENT OF A VESIVAS IMMUNOSIMILAR FORMULATION
Department of Health and Human Services · $569,807 · Aug 1, 2021
THE CONTRACTOR SHALL TO ENGINEER NOVEL HIV GP41 ECTODOMAIN ANTIGENS (HIV GP41E-HD) FOR THE INCORPORATION INTO THE IMMUNOGENIC VESIVAX FORMULATIONS.
Department of Health and Human Services · $300,000 · Jul 1, 2022
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids